Effects of noradrenaline, the calcium ionophore A23187, forskolin, sodium nitroprusside and glibenclamide on the degradation of extracellular adenosine 5'-triphosphate by the rat isolated vas deferens

Journal of Autonomic Pharmacology

Volumn 19, Issue 3, 1999, Pages 167-171

  Tennant, J P ^a   Pearson, A ^a   Hourani, S M O ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIMYCIN; CALCIUM IONOPHORE; FORSKOLIN; GLIBENCLAMIDE; INOSINE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HALF LIFE TIME; MALE; NONHUMAN; NUCLEOTIDE METABOLISM; RAT; VAS DEFERENS;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIMYCIN; FORSKOLIN; GLYBURIDE; INOSINE; MALE; NITROPRUSSIDE; NOREPINEPHRINE; RATS; RATS, WISTAR; TIME FACTORS; VAS DEFERENS;

EID: 0032864114     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1999.00129.x     Document Type: Article

References (30)

1. ABRAHAM, S.T. & RICE, P.J. (1992). Protein kinase C-mediated contractile response of the rat vas deferens. Eur. J. Pharmacol., 218, 243-249.
2. 2-purinoceptors mediating contraction of guinea-pig vas deferens and urinary bladder. Br. J. Pharmacol., 112, 219-225.
3. 1 receptor agonist of agents inducing contraction of the rat vas deferens. Naunyn-Schmiedeberg's. Arch. Pharmacol., 353, 499-504.
4. BÜLTMANN, R., PAUSE, B., WITTENBURG, H., KURZ, G. & STARKE, K. (1996a). P2-Purinoceptor antagonists, 1. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates. Naunyn-Schmiedeberg's. Arch. Pharmacol., 354, 481-490.
5. 2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens. Naunyn-Schmiedeberg's. Arch. Pharmacol., 349, 74-80.
6. BÜLTMANN, R., WITTENBURG, H., PAUSE, B., KURZ, G., NICKEL, P. & STARKE, K. (1996b). P2-Purinoceptor antagonists. 3. Blockade of P2-purinoceptor subtypes and ecto-nocleotidases by compounds related to suramin. Naunyn-Schmiedeberg's. Arch. Pharmacol., 354, 498-504.
7. BURNSTOCK, G. (1995). Noradrenaline and ATP: cotransmittets and neuromodulators. J. Physiol. Pharmacol., 46, 365-384.
8. DIAMOND, J. & JANIS, R.A. (1978). Increases in cyclic GMP levels may not mediate relaxant effects of sodium nitroprusside, verapamil and hydralazine in rat vas deferens. Nature, 271, 472-473.
9. HÄGGBLAD, J. & FREDHOLM, B.B. (1987). Adenosine and neuropeptide Y enhance adrenoceptor-induced accumulation of inositol phosphate; and attenuate forskolin-induced accumulation of cyclic AMP in rat vas deferens. Neurosci. Lett., 82, 211-216.
10. HOURANI, S.M.O., DI VIRGILIO, F. & LOUBATIERES-MARIANI, M.M. (1998). Physiological roles for P2 receptors in platelets, visceral smooth muscle and the immune and endocrine systems. In: The P2 Nucleotide Receptors, pp. 361-411 (eds J. T. Turner, G. A. Weisman & J. S. Fedan). Humana Press, Inc., Totowa, NJ.
11. 1 receptors in the rat vas deferens. Gen. Pharmacol., 25, 417-420.
12. 1-purinoceptors in rat vas deferens. Br. J. Pharmacol., 108, 754-758.
13. HOYLE, C.H.V. (1992). Transmission: purines. In: Autonomic Neuroeffector Mechanisms, pp. 367-407 (eds G. Burn-stock & C. H. V. Hoy]e ). Harwood, Reading, UK.
14. IJZERMAN, A.P. & VAN DER WENDEN, N.M. (1998). Modulators of adenosine uptake, release, and inactivation. In: Purinergic Approaches in Experimental Therapeutics, pp. 129-148 (eds K. A. Jacobson, & M. F. Jarvis). Wiley-Liss Inc. NY.
15. 2x purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens. Br. J. Pharmacol., 115, 177-185.
16. 2 receptors in guinea-pig aorta. J. Pharm. Exp. Ther., 269, 1228-1235.
17. MINAMINO, T., KITAKASE, M., MORIOKA, T., NODE, K., KOMAMURA, K., TAKEDA, H., INOUE, M., HORI, M. & KAMADA, T. (1996). Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity. Am. J. Physiol., 270, H238-H244.
18. MORRIS, J.L. & GIBBINS, L.L. (1992). Co-transmission and neuromodulation. In: Autonomic Neuroeffector Mechanisnis, pp. 33-119 (eds G. Burnstock & C. H. V. Hoyle), Harwood, Reading, UK.
19. MULLER, N.J. & PATON, D.M. (1979). Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination. Naunyn-Schmiedeberg's Arch. Pharmacol., 306, 23-28.
20. NODE, K., KITAKASE, M., MINAMINO, T., TADA, M., INOUE, M., HORI, M. & KAMADA, T. (1997). Activation of ecto-5′-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart. Br. J. Pharmacol., 120, 273-281.
21. OBATA, T., SATO, T., YAMANAKA, Y. & ARITA, M. (1998), NO and cGMP facilitate adenosine production in rat hearts via activation of ecto-5′-nucleotidase. Pflügers Arch., 436, 984-990.
22. 1 receptors. J. Auton, Pharmacol., 1, 287-290.
23. SATO, T., OBATA, T., YAMANAKA, Y. & ARITA, M. (1997). The effect of glibenclamide on the production of interstitial adenosine by inhibiting ecto-5′-nucleotidase in rat hearts. Br. J. Pharmacol., 122, 611-618.
24. SATO, T., OBATA, T., YAMANAKA, Y. & ARITA, M. (1998). Effects of lysophosphatidylcholine on the production of interstitial adenosine via protein kinase C-mediated activation of ecto-25′-nucleotidase. Br. J. Pharmacol., 125, 493-498.
25. SCHULTZ, K.-D., SCHULTZ, K. & SCHULTZ, G. (1977). Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature, 265, 750-751.
26. TENNANT, J.P., SAMUEL, A. J. & HOURANI, S.M.O. (1997). Ectonucleoridase activity in the prostatic and epididymal portions of the guinea-pig vas deferens. Br. J. Pharmacol., 122, 146P.
27. TULUC, F., BULTMANN, R., GLAMZEL, M., FRAHM, A.W. & STARKE, K. (1998). P2-Receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue-2. Naunyn-Schmiedeberg's Arch. Pharmacol., 357, 111-120.
28. 2x, receptor for extracellular ATP. Nature, 371, 516-519.
29. WITTENBURG, H., BÜLTMANN, R., PAUSE, B., GANTER, C., KURZ, G. & STARKE, K. (1996). P2-Purinoceptor antagonists. 2. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 498-504.
30. ZIMMERMANN, H., BRAUN, N. & NOCKEN, F. (1995). Extracellular hydrolysis of ATP and adenosine in the nervous system. In: Adenosine and Adenine Nucleotides: from Molecular Biology to Integrative Physiology, pp, 179-188 (eds L. Belardinelli & A. Pelleg). Kluwer Academic Publishers, Boston, MA.